ABSTRACT The ability of acetylcholine (ACh) to inhibit 13-agonist stimulated calcium current was compared to its ability to activate the inwardly rectifying potassium current Ig(ACh) in frog atrial myocytes. As suggested by previous studies, ACh inhibited the calcium current at concentrations (ECs0 = 8 nM) significantly lower than those required for the activation of IK(ACh) (ECs0--101 nM). The pharmacological profiles of the two responses suggest that despite the differences in agonist sensitivity, both are mediated by the same (m~) type of muscarinic receptors. Intracellular application of GDPI3S, an inhibitor of G protein function, completely abolished both responses, implying that both actions of ACh are coupled to effectors by G proteins. In contrast, intracellular application of pertussis toxin (PTX) shifted to higher concentrations (ECs0 = 170 nM) but did not abolish inhibition of the calcium current by ACh even though the block of the IK(ACh) response was complete. Increasingly large PTX concentrations and/or prolonged PTX treatments revealed a limiting, FTX-resistant inhibitory component that appears to be mediated by a FFX-insensitive G protein distinct from that mediating IK(ACh)-For the FIX-sensitive components, the different agonist dependencies of
INTRODUCTION
Acetylcholine alters cardiac function by acting on several cellular regulatory pathways. For ion channels, the most prominent of these include the inhibition of the L-type calcium current induced by 13 adrenergic agonists and the activation of the inwardly rectifying potassium current, IKtACh).I Both of these effects are blocked by atropine and are therefore mediated by activation of muscarinic cholinergic receptors (Giles and Noble, 1976; Breitwieser and Szabo, 1985; Fischmeister and HartzeU, 1986 ; for recent reviews see Hartzell, 1988; Trautwein and Hescheler, 1990; Szabo and Otero, 1990) . In atria, the two pathways coexist, whereas in ventricular tissues IK(ACh) tends to be less prominent or absent (Giles and Imaizumi, 1988) . Note that in both tissues there is a small, agonist-independent calcium current that is not affected by ACh (see Trautwein and Hescheler, 1990; Fischmeister and HartzeU, 1986 ). In order not to confuse this basal component with the L-type/Ca observed as a result of ~3-adrenergic stimulation, we shall designate the latter as 13-/Ca.
IKCACh) is coupled to muscarinic receptors via the guanine nucleotide binding protein GK that, upon activation by agonist bound receptor, increases the open probability of the inwardly rectifying IKtACh) channel through a membrane delimited process (Breitwieser and Szabo, 1985; Pfaffinger, Martin, Hunter, Nathanson, and HiUe, 1985; Brown and Birnbaumer, 1990) . f3-Ica results from an increased open probability of Ca 2 § channels by way of a complex process involving {3-adrenergic receptor dependent activation of adenylyl cyclase via the G protein Gs, leading to activation of the cAMP dependent protein kinase-A and phosphorylation of the L-type Ca 2+ channel or associated protein (Tsien, Bean, Hess, Lansman, Nilius, and Nowycky, 1986; Hecheler, Kameyama, and Trautwein, 1986 , for a review, see Trautwein and Hescheler, 1990) . Muscarinic inhibition of 13-lca may affect any one or several of these steps. Previous work suggests that a significant portion of the inhibitory action of ACh is on adenylyl cyclase by way of an inhibitory G protein (Breitwieser and Szabo, 1985; Nakajima, Wu, Irasawa, and Giles, 1990; Parsons, Lagrutta, White, and Hartzell, 1991) . Other concomitant mechanisms, however, have not been ruled out Fischmeister and Shrier, 1989) . The objective of this work was to examine the mechanisms by which muscarinic receptors modulate different effectors under physiological circumstances using the whole-cell patch clamp technique. In particular, we wanted to determine if the actions of ACh on IK(ACh) and 13-Ica are mediated by the same type of muscarinic receptors, if this action is mediated exclusively via G proteins and if so, whether or not the participating G proteins are identical.
METHODS

Solutions and Drugs
The composition of the solutions given below is in millimolar. Ca~+-free Ringer for the preparation of atrial myocytes: 110 NaC1, 5.4 KCI, 1.0 MgCI~, 10 HEPES, pH 7.2 adjusted with NaOH. Dissociation medium: CaZ+-free Ringer supplemented with 1.2 mg/ml collagenase (Boehringer Mannheim Biochemicals, Indianapolis, IN) and 0.08 mg/ml protease (Type XIV, Sigma Chemical Co., St. Louis, MO). Normal K + Ringer solution: 90 NaC1, 2.5 KCI, 5 MgC12, I A functionally important hyperpolarization-activated muscarinic-inhibited cation current, observed in mammalian atrial myocytes (If), has also been reported to have a high, nanomolar sensitivity to ACh (DiFrancesco, Ducouret, and Robinson, 1989) . A similar current exists in cells of the frog sinus venosus but not those of the atria (Bois and Lenfant, 1990 ).
2.5 CaCI~, 5 x 10 -3 tetrodotoxin, 20 HEPES, pH 7.4 adjusted with NaOH (~9 raM). Cs § Ringer: 20 CsCI, 85 NaCI, 2.0 MgCI2, 2.0 CaCI~, 5 x 10 -3 tetrodotoxin, 20 HEPES, pH 7.4 adjusted with NaOH. Normal internal solution for the patch pipette: 80 K-aspartate, 30 KCI, 0.5 EGTA, 5.0 HEPES, 2.5 MgATP, 0.2 GTP, pH 7.4 adjusted with KOH. Cs + internal solution: 120 CsC1, 0.5 EGTA, 5.0 HEPES, 2.5 MgATP, 0.2 GTP, pH 7.4 with KOH. For experiments with pertussis toxin, the internal solutions were supplemented with 50 p,M [3NAD.
Pertussis toxin (PTX; 100-400 p,g/ml in PBS) and RR toxin (see below) were a gift from Dr. Erik Hewlett, University of Virginia, Charlottesville, VA. Shortly before use, VFX was activated for 15 min at 35~ in a solution containing 1.0 Na~ATP, 2.0 Na~EGTA, 0.5% wt/vol Lubrol PX, 0.03% wt/vol bovine serum albumin, 10 Tris, 20 dithiothreitol, pH 7.5 and the PTX stock diluted twofold. The activated FIX was diluted with internal solution as necessary (usually to 4 p,g/ml). In control experiments solutions "activated" without PTX and, in some cases substituting a mutant toxin (RR toxin) unable to ADP ribosylate G proteins (Pizza, Covacci, Bartoloni, Perugini, Nencioni, DeMagistris, Villa, Nucci, Manetti, Bugnoli, Giovannoni, Barbieri, Sato, and Rappuoli, 1989) , were used to ascertain that no effects are seen in the absence of ADP ribosylation.
The drugs used in the experiments were (-) isoproterenol (Iso), acetylcholine, atropine, pirenzepine, forskolin, all from Sigma Chemical Co. Forskolin was prepared as a stock solution of 10 mM in anhydrous ethanol; isoproterenol solutions were prepared before each experiment from a stock solution (1 mM) containing 1 mM ascorbic acid. AF-DX 116 was a gift of Boehringer Ingelheim (Reims, France).
Preparations
Bullfrog (Rana catesbeiana) atrial cells were isolated as described in Breitwieser and Szabo (1988) . Briefly, the frog was killed by decapitation and pithing; the heart was removed and washed in, and then perfused at 30~ for 25 min with Ca~ § Ringer solution, which had been thoroughly oxygenated by bubbling with 100% O~. Subsequently, the heart was perfused for ~ 30 rain with dissociation medium. The atrium was removed and suspended in low calcium Ringer (Ca2+-free solution supplemented with 200 o,M CaCI2). The tissue was stored in the refrigerator (4~ for up to 2 d. Myocytes were obtained by gentle agitation of the tissue in the suspension medium.
Sarcolemma was purified from bullfrog and beef heart according to the procedures of Otero and Szabo (1988) and Jones (1988) , respectively. Specific activity of muscarinic cholinergic binding sites (measured as [3H] quinuclidinyl benzilate binding sites) in sarcolemmal preparations were 6-7 pmol/mg (frog) and 3-4 pmol/mg (beef). Before ADP ribosylation, membranes (3.5-4.2 mg/ml) were diluted with one volume of DNAse I (2.5 p.g/ml) and Lubrol PX (0.1% wt/vol). Pertussis toxin (170 I~g/ml in PBS) was mixed with an equal volume of 100 mM glycine (pH 8.0 with NaOH), 40 mM DTY and 2% (wt/vol) BSA, and activated for 20 rain at 350C. In controls the toxin was replaced by PBS. ADP-ribosylation of membranes (17.5 and 21 Ixg protein for beef and frog, respectively) by activated toxin (0.6 p,g) was performed in a volume of 60 p.l; the final composition of the assay mixture was: 10 mM thymidine, 1 mM ATP, 1 mM EDTA, 0.1 mM GTP, 20 mM Tris (pH 7.8 with HCI) and 5 ~M [32P]NAD (7,500 dpm/pmol). After 2 h at 220C the reaction was quenched with 120 p~l of ice-cold NAD 10 mM (pH 7.5 with Tris) and the samples were centrifuged in an Airfuge (Beckman Instruments, Fullerton, CA) at 197,000 g for 5 rain. Pellets were suspended in Laemmli's sample buffer and reduced with 5 mM DTT for 1 h at 50~ followed by alkylation with 20 mM NEM for 15 rain at 220C. Samples were loaded on 10% SDS-polyacrylamide gels (16 • 14 cm) and electrophoresed according to Laemmli. The gels were stained with Coomassie Brilliant Blue to verify recoveries, dried and autoradiographed for 24-48 h.
Experimental Arrangements
The whole-cell recording configuration of the tight-seal technique (Hamill, Marty, Neher, Sakmann, and Sigworth, 1981) was used. Cells were allowed to settle in a recording chamber and superfused with extracellular solution. Patch pipettes were fabricated from square bore borosilicate glass (Glass Co. of America, Millville, NJ) using a Flaming-Brown P 80/PC electrode puller (Sutter Instruments Co., San Rafael, CA) and had resistances between 2 to 5 Mr/when filled with standard intracellular solution. Membrane currents were measured using an Axopatch 200A current to voltage converter (Axon Instruments, Inc., Foster City, CA). Some experiments were performed using custom-built electronics described in Breitwieser and Szabo (1988) . Ag/AgCI electrodes were used to establish electrical contact with pipette and bathing solutions. The signal from the current to voltage converter was filtered (5 KHz, 8 dB/octave Bessel), recorded for archival on magnetic media and digitized using a DSP-assisted data acquisition board (DAP 2400, Microstar Laboratories, Bellevue, WA) with 12-bit precision at a rate of 1,000 samples/s and analyzed on-line using software integral to the DAP 2400. Voltage clamp command potentials were also generated by the DAP 2400. Most data were obtained from ionic currents in response to 250-ms depolarizing pulses to -5 mV from a holding potential of -85 mV, applied at a rate of 0.67 Hz. (standard protocol). Initial peak inward currents and steady state pulse-end currents (10 ms average) were calculated for each response. Calcium currents were calculated as peak inward minus steady state current. Muscarinic K + currents were calculated as the change in the pulse-end steady state current after a 1.5-min exposure to extracellular ACh. For some experiments 1K(ACh) was measured by clamping the membrane potential to -35 mV and continuously monitoring the membrane current during exposure to extracellular ACh.
Rapid changes of the extraceUular solution were obtained by placing the cell near the tube from which solution was perfusing the recording chamber at a velocity of ~5 cm/s and switching between different solutions using a rotary valve. This arrangement allowed complete solution changes within 50 ms. Solutions were applied to the interior of the cell via the patch electrode that could be perfused during the experiment using the pressure injection method described elsewhere (Lapointe and Szabo, 1988) .
Mean values -+ SEM are given in the text. Curve fitting and statistical analysis were performed using the computer program SigmaPlot (landel Scientific, San Rafael, CA). All experiments were carried out at room temperature (21-23~
RESULTS
Differential Effects of ACh on Ica and IK(ach) in Atrial Myocytes
A review of previous data suggests that acetylcholine inhibits I~-Ica at significantly lower concentrations than those required for eliciting IK(ACh) although direct comparisons on the same preparation and under identical circumstances are usually not available (but see Giles and Noble, 1976; Nargeot, Gamier, and Rougier, 1981) . We have examined this issue by determining the dose-effect relationships in frog atrial myocytes where both/K(ACh) and ~-Ica are present.
The dose dependence OflK(ACh)was determined by measuring quasi steady state K + currents induced by 1.5 min. exposure to extracellular ACh using the voltage clamp pulse protocol described in Methods. Care was taken to separate successive agonist applications by at least 3 min so that the cell could recover from any desensitization of the response (Pappano and Mubagwa, 1991) . Under these conditions the dose dependence of IK(ACh) was independent of the order in which various ACh concentra-tions were applied. Typical traces are shown in Fig Corresponding experiments for the inhibition of [~-Ica were carried out in Cs + containing internal and external solutions in order to eliminate any interference from ACh induced K + currents. Isoproterenol (Iso, 2 I~M) was used to elicit a maximal 13-lca response. After the current stabilized, increasing concentrations of ACh were applied to assay the dose dependence of the muscarinic inhibition. Calcium currents were measured as the peak inward current relative to the current measured at the end of 250 ms depolarizations to -5 mV from a holding potential of -85 InV. These transients, obtained at 5.25-s intervals, were plotted as a function of time as shown in Fig. 1 B for a typical experiment. Note that at the lowest concentrations (near 1 nM) ACh often produced a slight increase in [3-lca, observed also in other preparations (Fischmeister and Shrier, 1989) , but not in the absence of Iso. Half maximal inhibition was always near 10 nM ACh and was independent of previous ACh applications provided that 13-Ica has been allowed to recover fully. The dose dependence of the inhibitory response is shown in Fig. 2 as filled circles. The dashed line is a nonlinear fit of data to the Michaelis equation yielding a maximal effect of 99% and a half-maximal inhibitory concentration ECs0 = 8.0 nM. Clearly, even in the same preparation and under the same experimental conditions, ACh is about an order of magnitude more potent in inhibiting 13-Ica than inducing IK(ACh).
Identification of Receptor Types
The difference in the potency of ACh for activation of IK(ACh) compared with the inhibition of f3-Ica raises the possibility that these muscarinic cholinergic effects are mediated via distinct receptor subtypes. This issue was addressed by the use of the subtype specific antagonists pirenzepine and AF-DX 116 (Nathanson, 1987) . For IK(ACh) the effects of these antagonists were determined from the magnitude of the outward current at the end of a 1-min application of 1 p,M ACh plus antagonist at a holding potential of -35 mV. The responses were normalized to control (1 txM ACh alone), obtained at least 3 min preceding the test responses in order to minimize any effects of desensitization. The results are shown in Fig. 3 A. The data were fitted to the Hill equation using nonlinear least squares procedure. With the maximal effect The relative effectiveness of the antagonists for relieving the muscarinic inhibition of 13-Ica was assessed by examining the magnitude of 13-Ica that reappeared after application of increasing concentrations of the antagonist together with 1 IxM Iso and 1 IxM ACh. The results of these experiments are shown in Fig. 3 B. The data were fitted to the Hill equation with the maximal effect set to 100%. For pirenzepine, the best fitting parameters were ICs0 = 1.7 txM and nH= 1.7 while for AF-DX 116 the corresponding parameters were IC50 = 2.3 p,M and nH= 1.44.
The AF-DX 116/pirenzepine ICs0 ratios are near unity, 1.3 and 0.74 for IK(ACh) and 13-Ica respectively, suggesting that similar or identical muscarinic receptor subtypes mediate these responses. One can estimate antagonist dissociation constants (Ki(amagonist)) using the relationship:
(1) Table I . compares these estimates to corresponding Ki's reported for a number of muscarinic receptor subtypes. 2 In contrast to mammalian cardiac mACh receptors (Hammer, Giraldo, Schavi, Monferini, and Ladinsky, 1986; Buckley, Bonner, Buckley, and Brann, 1989) , the bullfrog cardiac mACh receptor has high affinity for both pirenzepine and AF-DX 116, in a manner reminiscent of chick heart mACh receptors. Moreover, Table I bullfrog atrial mACh receptors and the m2mACh receptor subtypes identified in chick heart (Tietje and Nathanson, 1991) , suggesting that both the inhibition of fl-lca and the induction of IK(ACh) are mediated by muscarinic receptors similar to the m 2 subtype present in chick heart.
2 Note that Eq. 1 is valid only if the dose-response curve for antagonist has a Hill coefficient of one. Thus, the KD,antagonist values in Table I for [~-Ica may only be approximate.
Differential Effects of IntraceUularly Applied Pertussis Toxin
In an effort to distinguish the mechanisms by which muscarinic cholinergic stimulation inhibits 13-Ica and produces IK(ACh), we have examined the influence of pertussis toxin (trYX) on these processes. ~ inhibits Go/Gi type G proteins by ADP ribosylation of their c~ subunit (Hazeki and Ui, 1981) . PTX was applied intracellularly for two reasons. First, extracellularly applied PTX does not intoxicate frog myocytes unless FIX enters the cells through defects in the cell membrane (Li and Szabo, unpublished observations) . Second, intracellularly applied PTX acts rapidly, within minutes of its application. For optimal effects, PTX (usually 4 v,g/ml) was preactivated as described in Methods. The time course with which PTX inhibits IK(ACh) is illustrated in the upper trace of Fig. 4 , which plots steady state currents measured at the end of 250-ms depolarizations to -5 mV from a holding potential of -85 mV. IK(ACh) produced by 1 IxM ACh applied at 5-min intervals is seen to decrease in Tietje and Nathanson, 1991. ~Fukuda et al., 1989. amplitude and vanish after 10 min of intracellular FFX perfusion. The lower trace in Fig. 4 shows Ica measured and plotted as in Fig. 1 . Calcium current was elicited following a complete PTX induced block of IK(ACh) by applying Iso (1 IxM), at ~ 13 min in this experiment. In contrast with the total block of IK(ACh), PTX treatment did not eliminate inhibition of [3-Ica by 1 IxM ACh. While full PTX action, defined here by a complete loss of muscarinic IK(ACh) response, did not abolish muscarinic inhibition of [3-Ica, it altered markedly the dose dependence for agonist. A typical instance of this is shown in Fig. 5 where the ACh dose dependence of the [3-Ica inhibition was assayed following full PTX action. Rather than decreasing [3-Ica, the inward transients slightly increased following the application of 10 and 100 nM ACh. Inhibition of/Ca becomes evident only at 1 and 10 p~M ACh. This is in contrast with Fig. 1 , where in the absence of PTX half maximal inhibition of/Ca was seen for 8 nM ACh. Time (min) 949 FIGURE 4. Differential effects of FIX treatment on the ability of ACh to induce /K(ACh) and inhibit 13-1ca. IK(ACh) was measured at the end of 250-ms depolarizations to -5 mV from a holding potential of -85 mV, while /ca was measured as the peak inward current elicited during these same depolarizations. Data are plotted as a function of time (/K(ACh), upper trace; Ic~, lower trace). Note that since /K(ACh) transients contaminate the peak inward current,/ca was not plotted when a large/K(ACh) was present. Activated FIX (4 I~g/ml) was included in the patch pipette. Intracellular dialysis began at t = 0, the time at which the membrane under the patch pipette was ruptured. As expected, PTX eliminated IK(ACh) but not 13-Ic~ as shown by responses to extracellular applications of 1 p,M ACh and 1 p,M Iso (horizontal bars).
The ACh concentration dependence of/Ca after maximal PTX treatment is shown in Fig. 6 . Data from three to seven experiments of the type shown in Fig. 5 were averaged and plotted against the ACh concentration as filled triangles. The solid line was obtained by a nonlinear curve fitting procedure of the Michaelis equation yielding maximal inhibition of 72% and a half maximal inhibitory concentration of 170 nM. Note that the dose-effect relationship of the PTX-resistant muscarinic inhibition of j3-Ica is not affected by the order of ACh addition and/or previous exposure to ACh, provided that sufficient time is allowed for recovery between additions. As Fig. 6 indicates, the most significant effect of full PTX action is a shift of the dose-effect relationship to higher ACh concentrations; a secondary effect of reducing somewhat the maximal attainable inhibition is also seen.
We have considered the possibility that despite a complete inhibition of the IK(ACh) response by FIX, the remaining muscarinic inhibition of fl-Ica reflects an incomplete action of PTX on its G protein substrates. Thus, we have increased the PTX concentration in the patch pipette and extended the duration of the PTX treatment 
Involvement of G Proteins
We have also considered the possibility that part of the inhibitory response (e.g., the PTX resistant part) is not mediated by a G protein. If this is the case then maneuvers that block G protein function should reveal a residual inhibitory response. As we have shown previously, (Li, Otero, and Szabo, unpublished observations; see also Breitwieser and Pfaffinger et al., 1985) IKIACh) is completely blocked by intracellular application of 1 mM GDPJ3S. We have used this treatment to block G protein function in general. In the experiment shown in Fig. 7 B, IK(ACh) was abolished by 6 rain of GDPf3S application in a manner reminiscent of PTX treatment. Forskolin (50 ~M) was applied to stimulate/ca and ACh (1 ~.M) was then applied to test for residual inhibitory response. Fig. 7 B shows the lack of any inhibition Of/ca; in fact, one observes a slight enhancement of /Ca. Note that in the absence of intracellular GDP[3S one observes a large inhibition of/Ca (Fig. 7 A) in agreement with previous reports Fischmeister and Shrier, 1989) . The fact that intracellular GDPI3S completely abolishes the inhibitory response implies that both the FIX sensitive and the FIX resistant components of the muscarinic inhibition of 13-lca are mediated by G proteins. was applied during the decaying phase of the response. The time course of the control decay was fitted by an arbitrary function (the sum of two exponentials, as described in the text) and drawn as a solid line. The same function, scaled by a factor of 0.96, was drawn for the decaying phase of the second transient, obtained in the presence of ACb. The close agreement of the data points with the solid line indicates that ACh has little effect on the rate of J3-/ca decay.
Lack of Muscarinic Effects on the Recovery from Beta-Adrenergic Activation
It is possible that part of the muscarinic inhibition of [3-Ica does not result from inhibition of Ca 2 § channel activation by 13-agonist but rather an enhanced rate of recovery of the system from activation, for example due to enhanced cAMP degradation and/or increased phosphoprotein phosphatase activity. In this case application of ACh following a short pulse of Iso, when recovery is in progress, should accelerate the decay of ~-Ica. Fig. 8 shows that contrary to this expectation, the presence of ACh does not alter the decay of ~-Ica. Inward Ca 2 § transients elicited by depolarizing pulses of -5 mV from a holding potential of -85 mV were measured and plotted as in Fig. 1 . The first response shows 13-Ica induced by a 5-s application of 1 IxM Iso. The decay of 13-Ica could be approximated by a sum of two exponentials and a constant (solid line): I = a0 +Otl e-t/*I + or2 e-t/*2 (2) with ct0 = -100 pA, cxl = -436 pA, "q = 60 s, (x2 = -121 pA and 'I" 2 = 936 s. The second response was also induced by a 5-s application of 1 o~M Iso, however, 1 ~M ACh was applied during the recovery phase (horizontal bar). The solid curve for the recovery phase was drawn according to Eq. 2 using an offset ((x0) of -100 pA, the same time constants as for the first response, but with amplitudes ~1 and ~2 reduced by the same factor, 0.96. The curve approximates the experimental data closely, indicating that the time course of decay of 13-Ica is not significantly affected by muscarinic stimulation. Note that the same results are obtained when ACh is applied before the control response or when ACh is applied immediately following Iso (data not shown). Together with the observation of the effects of ACh on intracellular cAMP (Fischmeister and Hartzell, 1986 ; see Trautwein and Hescheler, 1990) , these data suggest that ACh has little or no effect on the deactivation of 13-Ic~. Thus, the PTX insensitive component of the muscarinic [3-Ica inhibition can not be explained by agonist effects on deactivation processes.
DISCUSSION
Differential Agonist Sensitivities of IK(ACh) and fl-Ica Inhibition
The muscarinic potassium current IKIACh) can be induced in sino-atrial, atrial and atrio-ventricular tissues, but it is not prominent in mammalian ventricle. 13-Ica is present in both atrial and ventricular tissues, but it has a larger amplitude in the ventricle. For these reasons IKIACU) has been studied in atrial tissues and 13-lca mostly in ventricular tissues (Giles and Noble, 1976) . Although not performed on the same preparation, these early studies nevertheless tended to suggest that ACh inhibits [3-Ica at concentrations significantly lower than those required to induce IK(ACh). Using the sucrose gap technique, Nargeot et al. (1981) observed differential sensitivities in frog atrial trabeculae, ECs0 of 80 nM and 1 o.M for [3-/Ca inhibition and IK(ACh), respectively. Here we extended these considerations to isolated bullfrog atrial myocytes using the patch clamp technique. We find a half maximal inhibition of ~~ by ACh of 8 nM which is significantly lower than that required to induce IK(ACh), 101
nM. The dose dependence of both effects can be fitted by the Hill equation using a Hill coefficient of one. It is interesting to note that at nanomolar concentrations ACh appears to stimulate [3-Ica slightly but consistently (see Fig. 1 A) , an effect that becomes more apparent following VFX treatment, see Fig. 5 . It is in fact possible that a rapidly developing, dose dependent potentiation of [3-Ica underlies the apparent lag seen for the inhibition of [3-Ica by ACh. Related observations have been reported by Gallo, Alloatti, Eva, Oberto, and Levi (1993) , albeit for much higher concentrations of agonist. It is likely that the ACh-induced increase of [3-/Ca is responsible for the lack of inhibitory response seen at 1 nM ACh ( Fig. 2; note that the data point falls below the dashed line). This phenomenon may also have physiological implications.
Identity of Receptor Subtypes Mediating I1r and [3-Ica Inhibition
We have addressed the possibility that Ik~ACh) and [3-/Ca respond to ACh differently because they are mediated by different types of muscarinic receptors. Mammalian receptor subtypes have been identified pharmacologically based on differences in ligand affinities; pirenzepine, a preferential antagonist of ml receptors, and AF-DX 116, a preferential antagonist of m2 receptors, have been particularly useful in this respect (Hammer et al., 1986; Buckley et al., 1989) . We have used these antagonists in an attempt to differentiate and identify the receptors acting on IK(ACh) and [3-Ica in bullfrog. In the presence of 1 ~,M ACh the ICs0 for decreasing IK~ACh) was 0.38 ~M and 0.49 ~M respectively for AF-DX 116 and pirenzepine. For the relief of ACh-induced block of [3-Ica the corresponding ICs0's were 2.3 ~M and 1.7 ~M, Fig.  3 . The relative antagonist potencies can be compared for these two actions of ACh by comparing AF-DX 116/pirenzepine ICs0 ratios which are 0.77 for IK~ACh) and 1.3 for [3-/Ca. Considering the range of corresponding relative potencies for the various receptor subtypes, some listed in Table I , these ratios are rather similar, suggesting that muscarinic receptors mediating the stimulation of IKIACh) and the inhibition of [3-Ica are not distinguishable.
It is also possible to estimate antagonist dissociation constants from the data of Fig.  3 provided that one makes certain assumptions about the underlying processes. For the simplest case, that of competitive binding, Ki's may be calculated using Eq. 1. This was done for IK(ACh) and [3-Ica using ECs0'S for ACh in the absence of antagonist (Fig. 2) . The results are shown in Table I , together with Ki's for selected muscarinic receptor subtypes. These are chick m2 receptors expressed in Chinese hamster ovary (Cm2/CHO); chick m2 receptors expressed in mouse Y1 cells (Cm2/Y1); chick m4 receptors expressed in Chinese hamster ovary (Cm4/CHO); chick m4 receptors expressed in mouse Y1 cells (Cm4/Y1) (Tietje and Nathanson, 1991) ; porcine ml, m2, and m3 receptors expressed in Xenopus oocytes (respectively Pml, Pm2 and Pm3) and rat m4 receptors expressed in Xenopus oocytes (Rm4) (Fukuda, Kubo, Maeda, Akiba, Hidaeki, Mishina, Higashida, Neher, Marty, and Numa, 1989) . Considering Ki's for mammalian receptor subtypes, typical values of which are shown in the last four rows of Table I , and corresponding data for muscarinic effects on IK(ACh) and [3-/Ca in bullfrog atria (first two rows), a lack of pharmacological similarity becomes apparent. For the mammalian receptor subtypes the AF-DX 116/pirenzepine Ki ratios are all much larger than unity except for Pm2. While this would suggest an mz-like character for the frog atrial receptors, the magnitude of the individual Ki's are at least 10-fold larger. In contrast, chick cardiac receptors (rows 4-6 in Table I ) show significant pharmacological similarities to the ones detected in frog. In particular, both the AF-DX 116 Ki's and the AF-DX 116/pirenzepine affinity ratios observed for the frog are very similar to those seen for chick m2 receptors. These considerations suggest that the muscarinic receptors that mediate the effects of ACh on IK(AUh) and [3-Ica in bullfrog atria are similar to the chick m 2 receptor subtype.
The antagonist dependence of the muscarinic inhibition of [3-Ica appears to be steeper than that OflK(ACh) (Fig. 3) . While our data do not have sufficient resolution to yield statistically well defined Hill coefficients, these are nevertheless clearly different from unity for the data of Fig. 3 B. This apparent cooperativity may reveal complexities in the system with respect to antagonist binding. An alternate possibility is that at low concentrations, antagonists have the simultaneous action of relieving inhibition of [3-Ica and inhibiting the small enhancement of [3-Ica by ACh. These effects may combine to give the appearance of a steeper than linear concentration dependence. As we have not found a way to eliminate the small, low concentration enhancement of [3-Ica by ACh, we can not rule out this possibility.
Taken together, these data indicate that differences in receptor subtypes can not be invoked to explain the differential sensitivity of IK(ACh) and 13-Iua to ACh. Note that AF-DX 116 blocks completely the inhibition of {3-Ic~ by ACh, implying that the response, including any trI'X insensitive component, is entirely mediated by muscarinic, Cm2-1ike receptors. It should be noted, however, that certain complexities may exist in the behavior of the system. Thus, for example, when nanomolar ACh concentrations are used, pirenzepine is significantly less potent than AF-DX 116 in reversing the inhibitory effect of ACh on 13-Ica (Hanf, Li, Szabo, and Fischmeister, 1993) . Further studies will be required to elucidate the basis of these complexities.
Part of the Muscarinic Inhibition of ~-Ica Is Not PTX Sensitive
Full inhibition of IK(ACh) implies that GK is subject to inactivation by ADP ribosylation. In contrast, the muscarinic inhibition of G'/Ca was not abolished by PTX although the EC50 was shifted to higher concentrations, from 8 nM to 170 nM ACh. It would appear, therefore, that muscarinic inhibition of [~-Ica is more complex than the activation of IK(ACh).
A possible reason for a PTX-resistant component is that in the frog Gi/Go type G proteins are resistant to ADP ribosylation. It has been reported, in fact, that recombinant So from the toad Xenopus shows reduced PTX sensitivity when compared to its mammalian counterparts (Blitzer, Omri, DeVivo, Carty, Premont, Codina, Birnbaumer, Cotecchia, Carron, Lefkowitz, Landau, and Iyengar, 1993) . This conclusion was based on experiments where amphibian and mammalian ~o were translated in vitro using the rabbit reticulocyte system, and subsequently ADP-ribosylated in the presence of presumably mammalian [3~. Because these experimental conditions, tailored to ensure efficient translation and modification of mammalian PTX substrates, are not necessarily optimal for amphibian PTX substrates, we performed experiments to investigate whether ADP ribosylation of frog Go/Gi-type G proteins is normal and comparable to that seen in mammalian systems. Fig. 9 shows the labeling pattern routinely observed when frog cardiac plasma membranes are ADP-ribosylated with pertussis toxin; results obtained with beef membranes run simultaneously through the procedure at comparable protein concentrations (21 i~g and 17.5 ~g respectively for frog and beef) are also shown. In frog cardiac sarcolemma, the bands that are specifically labeled by the toxin migrate with apparent molecular weights of 39-42 kD, with the lower Mr band(s) being more intensely labeled. ADP ribosylation of beef membranes gives essentially the same result (lane 3). This indicates that the ~-subunits of Gi/Go proteins in native SL membranes from bullfrog heart are as susceptible to ADP-ribosylation by pertussis toxin as those present in mammalian heart membranes. These data, together with the observation that extended treatments well beyond the times and concentrations required for complete suppression of IK(ACh) could not affect the residual muscarinic [3-/Ca inhibitory response, suggests a different molecular mechanism for the latter process.
It should be noted that while a large body of evidence suggests that G proteins couple muscarinic inhibition of 13-Ica, primarily through inhibition of adenylyl cyclase (Breitwieser and Szabo, 1985; Fischmeister and Shrier, 1989; Pappano and Mubagwa, 1991) , it is nevertheless possible that other mechanisms, possibly not mediated by G proteins, also contribute to the inhibitory response. Our observation that intracellular GDPI3S completely eliminated the inhibitory effect of ACh, even when the latter was applied at high concentrations suggests, however, that the inhibitory response is mediated entirely by G protein(s).
We find that intracellular GDP~S eliminates IK(ACh) and the muscarinic [3-Ica inhibition with a similar time course so that no residual muscarinic ~-Ica inhibition can be observed once the IKIACh) response vanishes (see Fig. 7 B) . This observation tends to rule out the possibility that a degree of PTX treatment sufficient to eliminate IK~ACh) may leave a residue of unreacted G protein that, because of a strong affinity for the cyclase, may appear as a FIX-insensitive component.
These considerations suggest that muscarinic inhibition of [3-Ica is mediated by at least two G proteins, only one of which is a substrate for ADP ribosylation by PTX. Inhibition of adenylyl cyclase by a PTX-insensitive G protein, Gz, has been reported previously (Wong, Conklin, and Bourne, 1992 ) and a similar type of G protein may be responsible for the PTX resistant inhibition of ~-Ica observed here. Further experiments using specific G protein reagents will be necessary to establish the identity of the Fl~-insensitive G protein involved in the inhibitory process.
Possible Mechanisms
The higher ACh sensitivity of the PTX-dependent [3-Ica inhibitory response relative to that of K + channel opening implies significant differences in these signal transduction pathways. The similarities in antagonist binding profiles suggest that the differences are not at the level of the receptor but rather at the level of the G protein/effector system. The most obvious possibility is that these two processes are mediated by different G proteins, that is GK is not identical to Gi. This must in fact be the case for that portion of [~-Ica which is not sensitive to PTX. In neuronal cells, cyclase activity is inhibited by Go while the direct activation of a K(ACh) channel is mediated by Gi3, that is to say GK and Gi are different G protein isoforms; this finding is consistent with the participation of two different G proteins in the effects of ACh (see Birnbaumer, 1992) . This hypothesis would also explain why desensitization to ACh occurs at a faster rate for the muscarinic activation of K + current than for the muscarinic inhibition of [3-Ica (Pappano and Mubagwa, 1991; Honjo, Kodoma, Zang, and Boyett, 1992 ). An alternative hypothesis, however, is that the same G protein is involved in both effects and the differences arise by way of interactions with the effector either directly through the formation of a preexisting G protein-effector complex or through differential rates of G protein-effector interactions and/or effector-modified rates of G protein deactivation. Kinetic arguments and the lack of cross-talk in agonist binding suggests that, at least in some specific cell types, G proteins are segregated into functional complexes (Graeser and Neubig, 1993) . Simple kinetic considerations suggest, however, that our results are also explained by a signal transduction system with mobile components, provided that G proteineffector interactions and G protein deactivation are allowed to be effector dependent. A mechanism of this type would require that inhibition of adenylyl cyclase be more effective and longer lasting than IK(ACh) activation. This may come about as a result of a lower affinity of activated G protein for the K + channel relative to cyclase and/or an increased deactivation rate for the G protein-K + channel complex. The later would imply that G protein deactivation may depend on G protein-effector interactions, as seen in other systems (Arshavsky and Bownds, 1992; Pages, Deterre, and Pfister, 1992; Wong et al., 1992) .
Recent experiments suggest that IK(ACh) activation is mediated by G protein [~/ subunits (Logothetis, Kurachi, Galper, Neer, and Clapham, 1987; Murphy, Graber, Garrison, and Szabo, 1993; Wickman, Iniguez-Lluhl, Davenport, Taussig, Krapivinsky, Linder, Gilman, and Clapham, 1994) while adenylyl cyclase inhibition is produced both by G protein a and 13~ subunits (Fang, Iniguez-Lluhl, Mumby, and Gilman, 1992) . A mechanism of this type could explain the differences in agonist sensitivities of IK(ACh) and 13-Ica without invoking a second G protein species which would be nevertheless required in order to take into account the PTX-insensitive component we observe. Note, however, that since IK(ACh) activation seems to have no 1~/specificity (Murphy et al., 1993; Wickman et al., 1994 ) the 13~/subunits produced by activation of PTX insensitive G proteins would be expected to activate IK(ACh). That this is not seen tends to argue against the subunit hypothesis.
During the preparation of this manuscript, nitric oxide has been reported to be an obligatory component of the muscarinic inhibition of [3-Ica in myocytes from the mammalian sino-atrial node (Han, Shimoni, and Giles, 1994 ). While we have no indication whether or not this mechanism is present in frog atrial myocytes, our data suggests that if it is present then it must be mediated via a G protein. Further experiments will be required to determine examine the relevance of this mechanism to our observations.
